Cary Owen Harding MD
Clinical Biochemical Genetics, Clinical Genetics
Associate Professor, Molecular & Medical Genetics, Oregon Health and Science University School of Medicine
Join to View Full Profile
707 SW Gaines StPortland, OR 97239
Phone+1 503-494-7859
Fax+1 503-494-4447
Dr. Harding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1987 - 1990
University of Washington School of MedicineClass of 1987
Certifications & Licensure
OR State Medical License 1999 - 2025
ID State Medical License 2004 - 2024
WI State Medical License 1988 - 1999
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- Longitudinal Study of Urea Cycle Disorders Start of enrollment: 2006 Feb 01
- Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders Start of enrollment: 2010 Dec 01
- Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- D-BHB supplementation before moderate-intensity exercise suppresses lipolysis and selectively blunts exercise-induced long-chain acylcarnitine increase in pilot study ...Ashley N Gregor, Philippe Delerive, Bernard Cuenoud, Irina Monnard, Karine Redeuil
Molecular Genetics and Metabolism. 2025-04-01 - Phenylketonuria in adults: we know plenty, but there is much more to learn.Cary O Harding, Georgianne Arnold, Gerard T Berry, Shawn E Christ, Dorothy K Grange
The American Journal of Clinical Nutrition. 2025-03-01 - Corrigendum to "Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data" [Molecular Genetics and Me...Fran Rohr, Barbara Burton, Anne Dee, Cary O Harding, Joshua Lilienstein
Molecular Genetics and Metabolism. 2024-12-01
Press Mentions
- BioMarin Pharmaceutical : , Pioneer in Rare Disease Treatments for Phenylketonuria, Receives FDA Approval of Label ExpansionOctober 15th, 2020
FDA Approves New Drug Tested at OHSU for Phenylketonuria, or PKU - Portland Business JournalMay 25th, 2018
BioMarin Sinks Despite Meeting Primary EndpointMarch 21st, 2016
Grant Support
- Hyperphenylalaninemia Disorders Consortium of the Rare Disease Clinical Research NetworkOREGON HEALTH & SCIENCE UNIVERSITY2019–2025
- Augmented Phenylalanine Clearance By Muscles As Novel Therapy For PhenylketonuriaEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2012
- AAV2/8 Vector-Mediated Liver Gene Therapy For Phenylketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Liver Gene Therapy For Murine Phenyketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2006
- Intravenous Non-Viral Gene Therapy For Phenylketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2006
- Stem Cell-Mediated Liver Repopulation For Murine PKUNational Heart, Lung, And Blood Institute2005–2006
- DHA Triglyceride Supplementation In Lchadd PatientsNational Center For Research Resources2004–2005
- Metabolic Engineering As Therapy For Murine PKUNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
- Docosahexaenoic Acid Triglyceride Supplementation In LchaddNational Center For Research Resources2000–2002
- DHA Triglyceride Supplementation In Long Chain Dehydrogenase Deficiency (LCHADD)National Center For Research Resources1998–2002
- Heterologous Gene Therapy For MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
- Aav-Mediated Gene Therapy--Inborn Errors Of MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1999
- Heterologous Gene Therapy For MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
